» Articles » PMID: 31933100

Pituitary Tumors: Epidemiology and Clinical Presentation Spectrum

Overview
Specialty Endocrinology
Date 2020 Jan 15
PMID 31933100
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Pituitary tumors (PTs) are a heterogeneous group of lesions of the central nervous system that are usually benign. Most of them occur sporadically, but 5% can do so within family syndromes, usually at a young age. There are differences by sex, age, race, and genetic factors in the prevalence of different tumor cell types and clinical presentation. Functioning-PTs (FPTs) are usually diagnosed earlier than non-functioning PTs (NFPTs). However, this depends on the PT type. Headaches and visual disturbances are the most frequent mass-effect symptoms, but seizures or hydrocephalus may also occur. Pituitary apoplexy is another possible mode of presentation, and it requires special attention because of its potential severity. PTs in pregnancy, childhood, and old age present a series of clinical peculiarities that must be taken into account when evaluating these patients. Ectopic PTs (EPTs) are uncommon and share the same clinical-epidemiological data as eutopic PTs, but, depending on their location, other types of clinical manifestations may appear. Silent PTs are often detected as an incidentaloma or due to neurologic symptoms related to mass-effect. Aggressive PTs and pituitary carcinomas (PCs), which are very rare, are characterized by multiple local recurrences and metastases, respectively. This review addresses the epidemiology and clinical presentation of PTs, from the classical hormonal and mass-effect symptoms to the different rare presentations, such as pituitary apoplexy, hydrocephalus, or diabetes insipidus. Moreover, special situations of the presentation of PTs are discussed, namely, PTs in pregnancy, childhood, and the elderly, EPTs, silent and aggressive PTs, and PCs.

Citing Articles

FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours.

Orsmond A, Krishnan G, Palmer L, De Sousa S, McCormack A Pituitary. 2025; 28(2):39.

PMID: 40064730 PMC: 11893631. DOI: 10.1007/s11102-025-01498-0.


The associations between risk factors and pituitary neuroendocrine tumors: A bidirectional Mendelian randomization study.

Wang W, Ma L, Liu M, Zhao Y, Ye W, Li X Medicine (Baltimore). 2025; 103(47):e40617.

PMID: 39809197 PMC: 11596971. DOI: 10.1097/MD.0000000000040617.


Elucidating the causal links between plasma and cerebrospinal fluid metabolites and pituitary tumors: a Mendelian randomization analysis.

Wang W, Liu M, Wang Z, Ye W, Li X Front Endocrinol (Lausanne). 2024; 15:1460278.

PMID: 39669498 PMC: 11634583. DOI: 10.3389/fendo.2024.1460278.


Combined coronary artery bypass grafting and orthopedic fixation in a patient with multiple comorbidities: a case report.

Natsha N, Najjar R, Warasna H, Awad M, Alhadad B, Marzouqa B Ann Med Surg (Lond). 2024; 86(12):7436-7443.

PMID: 39649932 PMC: 11623856. DOI: 10.1097/MS9.0000000000002719.


The prospective roles of exosomes in pituitary tumors.

Lisiewicz P, Szelachowska M, Kretowski A, Siewko K Front Endocrinol (Lausanne). 2024; 15():1482756.

PMID: 39649222 PMC: 11620868. DOI: 10.3389/fendo.2024.1482756.